News | Cardiovascular Ultrasound | October 15, 2020

GE Healthcare Receives FDA Clearance for AI-powered Cardiovascular Ultrasound System

The Vivid Ultra Edition, AI-powered cardiovascular ultrasound system is designed to shorten diagnostic exam time and improve measurement consistency

GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

October 13, 2020 — GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

Methodical assessments of heart function are key in echocardiography but can be tedious and timeconsuming to acquire. High quality data acquisition and operator skill are key elements to achieve accurate and complete exams. And, as patients undergo subsequent monitoring exams, the reproducibility of exam assessments is key to identifying improvement or disease progression. Vivid Ultra Edition brings increased efficiencies to the scanning process for reduced exam time through up to 80% fewer clicks, 99% accuracy and less inter-operator variability. 

“We use AI Auto Measure – 2-D, AI Auto Measure – Spectrum Recognition, and Auto AFI together with Auto EF. We also use Scan Assist Pro, 4-D biplane and 4-D triplane. All of this in combination has saved us 7 to 10 minutes per scan, which is fantastic, so we really do have more time to spend with the patient,” said Rebecca Perry, Ph.D., cardiac sonography program stream coordinator, University of South Australia, in a Vivid Talk webinar.

Vivid Ultra Edition features leverage AI-driven, neural network-based algorithms designed to deliver repeatable and faster measurements in 2-D echo imaging:

• AI Auto Measure – Spectrum Recognition can semi-automatically detect the appropriate measurement of spectral Doppler images, enabling the system to fast-forward the path from scanning to measurements with 98% accuracy and 100% reproducibility. 

• AI Auto Measure – 2-D can detect the relevant points in the image used to derive key measurements of the left ventricle, performing comparable to human users with 100% reproducibility. 

• AI-based View Recognition can automatically detect with 99% accuracy and 100% reproducibility which standard 2D scan plane is acquired and store this label in the image file. Our AFI package is designed to use these data to automatically select views for strain analysis, streamlining workflow and increasing efficiency.  

“With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers’ two key challenges in echo exams – how time consuming the exam is and the degree of variability that exists in the quantitative results,” said Dagfinn Saetre, General Manager of Cardiovascular Ultrasound at GE Healthcare. “This package supports our vision of where we need to go with cardiovascular ultrasound: tools to support less variability and improved productivity. The Vivid Ultra Edition is a solid step in our strategic roadmap.” Vivid Ultra Edition also provides uncompromised image quality and advanced visualization and navigation capabilities:

• HD Color displays anatomy and jet using shadowing, reflections and transparency to enhance the 3-D perception.

• FlexiLight offers photorealistic images to help improve visualization of moving structures and depth perception of tissues.

• 4-D TTE Pediatric probe (6VDc) provides excellent 2-D and 4-D imaging for a range of pediatric patients from neonates to teenagers.

For more information: gevividultraedition.com/3d-map


Related Content

News | Cardiac Imaging

Pfizer has awarded $80,000 to Rutgers Robert Wood Johnson Medical School (RWJMS) to fund an Amyloidosis Fellowship at ...

Home December 19, 2024
Home
News | Cardiac Imaging

Dec. 11, 2024 — Genetesis, Inc. has launched the CardioFlux Membership program. CardioFlux Membership is designed to be ...

Home December 18, 2024
Home
News | Cardiac Imaging

Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing ...

Home November 13, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage ...

Home October 16, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend ...

Home October 15, 2024
Home
News | Cardiac Imaging

PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy ...

Home October 01, 2024
Home
News | Cardiac Imaging

Aug. 21, 2024 — NANO-X IMAGING LTD recently announced that its deep-learning medical imaging analytics subsidiary, Nanox ...

Home August 22, 2024
Home
News | Cardiac Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Home July 23, 2024
Home
News | Cardiac Imaging

July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...

Home July 12, 2024
Home
News | Cardiac Imaging

June 10, 2024 — New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously ...

Home June 10, 2024
Home
Subscribe Now